KMO inhibitor drug improves lifespan of Huntington's disease mice

KMO inhibitor drug improves lifespan of Huntington's disease mice

Positive results from tests of a new 'KMO inhibiting' drug in Huntington's disease mice

Professor Ed WildJune 02, 2011

Meet the enemy: neutron ray reveals HD protein structure

Meet the enemy: neutron ray reveals HD protein structure

Scientists use beams of neutrons to study the structure of clumps of mutant huntingtin protein

Dr Jeff CarrollMay 26, 2011

'Floating' gene-silencing drugs into the brain with exosomes

'Floating' gene-silencing drugs into the brain with exosomes

Exosomes – tiny bubbles made by cells – could be used to get gene silencing drugs from the bloodstream into the brain

Professor Ed WildMay 19, 2011

Improving Huntington's disease clinical trial recruitment through patient and family education

Improving Huntington's disease clinical trial recruitment through patient and family education

How can we improve recruitment into Huntington's disease clinical trials? Talking directly with families works!

Dr Jeff CarrollMay 12, 2011

Chubby mice reveal the importance of the hypothalamus in Huntington's disease

Chubby mice reveal the importance of the hypothalamus in Huntington's disease

Huntington's disease mice are fat but HD patients lose weight – is a brain area called the hypothalamus to blame?

Professor Ed WildMay 02, 2011

The genetic 'gray area' of Huntington's disease: what does it all mean?

The genetic 'gray area' of Huntington's disease: what does it all mean?

Intermediate alleles and reduced penetrance – the genetic 'gray area' of Huntington’s disease, explained

Dr Nayana LahiriApril 22, 2011

Dimebon fails in late-stage human HD clinical trial

Dimebon fails in late-stage human HD clinical trial

Dimebon fails to improve symptoms in HD patients in the HORIZON trial

Dr Jeff CarrollApril 11, 2011

FDA: further trial needed for Huntexil approval in HD

FDA: further trial needed for Huntexil approval in HD

Bad news for Huntexil – the FDA requires another trial before it can be approved in the US

Dr Jeff CarrollApril 04, 2011

Successful gene therapy trial in Parkinson’s Disease gives hope for HD

Successful gene therapy trial in Parkinson’s Disease gives hope for HD

Success for brain ‘gene therapy’ in Parkinson’s disease – good news for similar treatments being developed in HD

Dr Jeff CarrollMarch 31, 2011

Gene silencing for HD: the story so far

Gene silencing for HD: the story so far

Is gene silencing as exciting as it sounds for HD, and what might the future hold?

Professor Ed WildMarch 22, 2011

Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis

Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis

HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc

Professor Ed WildMarch 14, 2011

Donate

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.

With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you're able. More information...